Status:
WITHDRAWN
Intrathecal Morphine Microdose Method Sensory Changes
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Conditions:
Analgesic Drug Dependence
Sensory Disorders
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Following the retrospective study on the effectiveness of the microdose method of intrathecal morphine therapy, the investigators are interested in measuring the sensory changes at 4 time points durin...
Detailed Description
The use of intrathecal drug delivery systems for the management of chronic non-cancer pain has been in practice for over 30 years. A recently published study from the University of Texas Medical Branc...
Eligibility Criteria
Inclusion
- Age between 18 and 75
- Selected for microdose Intrathecal pump therapy by their pain physician
- Chronic pain for at least 3 months
- Willing to cooperate with all study procedures
Exclusion
- Presence of cancer
- Age less than 18 years old or greater than 75
- Current intrathecal therapy and/or with multiple intrathecal drugs (such as other opioids, local anesthetics, muscle relaxants)
- Medical conditions (myocardial infarction within the last year, uncontrolled diabetes, autoimmune disease
- Recent history of alcohol or substance abuse in the last 5 years
Key Trial Info
Start Date :
October 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 3 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03395275
Start Date
October 8 2018
End Date
February 3 2023
Last Update
March 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.